Bridgefront Capital, LLC Alkermes Plc. Transaction History

Bridgefront Capital, LLC

  • $278 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$23.37 - $32.13 $317,761 - $436,871
-13,597 Closed
0 $0
Q2 2021

Aug 12, 2021
BUY
$18.78 - $25.15 $255,351 - $341,964
13,597 New
13,597 $333,000
Q1 2021

May 17, 2021
SELL
$18.21 - $23.2 $409,907 - $522,232
-22,510 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$15.39 - $22.1 $346,428 - $497,471
22,510 New
22,510 $449,000

Others Institutions Holding ALKS

# of Institutions
375
Shares Held
166M
Call Options Held
231K
Put Options Held
158K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $5.45B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Bridgefront Capital, LLC Portfolio

Follow Bridgefront Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgefront Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgefront Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email